Dr. Mohamed Adel Osman Taha is an accomplished physician-scientist whose work bridges clinical neurology, neuromuscular medicine, and advanced applications of artificial intelligence in neurological diagnostics. His academic and clinical training spans leading global institutions, including fellowships in Advanced General & Autoimmune Neurology at Massachusetts General Hospital, Neuromuscular Medicine at the Cleveland Clinic Foundation, and Neurohospitalist Medicine at Stanford University. He also holds advanced master’s degrees in Stem Cells and Translational Neurology from the University of Edinburgh and in Genomic Medicine from the University of Manchester, reflecting a deep interdisciplinary foundation in neuroscience, genetics, and regenerative neurology. Dr. Taha’s research focuses on leveraging digital health technologies, AI-driven diagnostic tools, and advanced neurophysiology to improve the detection, characterization, and management of neuromuscular and neurodegenerative disorders. His scholarly contributions include impactful studies on electromyography signal classification using artificial intelligence, the clinical reliability of ICD-10 coding for stroke severity, and the role of AI in electrodiagnostic medicine—work published in high-impact journals such as Muscle & Nerve, BMJ Neurology Open, and npj Digital Medicine. These efforts underscore his commitment to translating computational innovations into precise, scalable clinical tools. His published research encompasses artificial intelligence in EMG and seizure detection, digital biomarkers, genotype–phenotype correlations, stroke outcome evaluation, and the interactions between neurologic therapeutics and anticoagulants. Dr. Taha has also contributed to the understanding of rare neurological diseases, leukoencephalopathies, and epilepsy-related challenges through case reports, systematic reviews, and population-based studies. His contributions extend to multi-institutional collaborations, including establishing neurocritical EEG databases and developing deep learning models for neuromuscular disease assessment. He has authored book chapters, research protocols, peer-reviewed abstracts, and numerous conference presentations at major neurological scientific meetings, including the American Academy of Neurology, the American Epilepsy Society, and the American Association of Neuromuscular & Electrodiagnostic Medicine. His book chapter on digital health in neurology further highlights his forward-looking approach to integrating technology with clinical practice. Beyond research, Dr. Taha has contributed significantly to academic medicine through resident education, cross-continental neurology outreach initiatives, and the founding of research groups aimed at strengthening scientific capacity in underserved regions. His growing body of work reflects a strong commitment to innovation, interdisciplinary collaboration, and improving neurological care through data-driven, technology-enhanced solutions.
Featured Publications
Elamin, E. M., Guizani, I., Guerbouj, S., Gramiccia, M., El Hassan, A. M., & others. (2008). Identification of Leishmania donovani as a cause of cutaneous leishmaniasis in Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 102(1), 75–80.
Taha, M. A., & Morren, J. A. (2024). The role of artificial intelligence in electrodiagnostic and neuromuscular medicine: Current state and future directions. Muscle & Nerve, 69(3), 260–272.
Taha, M., Li, W., Schmidt, C. M., Gonzalez-Castellon, M., & Taraschenko, O. (2020). The interactions between anticonvulsants and non-vitamin K antagonist oral anticoagulant agents: A systematic review. Epilepsy Research, 162, 106304.
Saab, K., Tang, S., Taha, M., Lee-Messer, C., Re, C., & Rubin, D. L. (2024). Towards trustworthy seizure onset detection using workflow notes. npj Digital Medicine, 7(1), 42.
Elimam, A. A., Aabdein, M. E. M. M., Eldeen, M. E. F. M., Altayb, H. N., Taha, M. A., & others. (2017). Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer. BMC Medical Genetics, 18(1), 85.
Hamid, O., Taha, M. A. O., Balla, S. A., & Hussien, A. (2013). Stigma of epilepsy among patients and their relatives attending charity clinic, Omdurman—Sudan. Journal of the Neurological Sciences, 333, e61–e62.
Hassan, A., El-Sayed, S., & Taha, M. (2012). Impact of a designed educational program on thyroidectomy patients’ discharge compliance instructions. Journal of American Science, 8(11), 1–3.
Taha, M., Li, Y., Morren, J., & Morren, J. A. (2023). Oxymetazoline hydrochloride eye-drops as treatment for myasthenia gravis-related ptosis: A description of two cases. Cureus, 15(3).